metformin has been researched along with Gastroparesis in 3 studies
Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.
Gastroparesis: Chronic delayed gastric emptying. Gastroparesis may be caused by motor dysfunction or paralysis of STOMACH muscles or may be associated with other systemic diseases such as DIABETES MELLITUS.
| Excerpt | Relevance | Reference |
|---|---|---|
| " (MS) bark juice in diabetic gastroparesis and its effect on pharmacokinetic of metformin (MET)." | 7.83 | Influence of Musa sapientum L. on pharmacokinetic of metformin in diabetic gastroparesis. ( Darvhekar, V; Jyotishi, SG; Mazumder, PM; Shelke, PG; Tripathi, AS, 2016) |
| " The prevalence of gastroparesis symptoms is 6% and is independently related to metformin use, and therefore, symptomatic screening is required to decide which patients need further evaluation." | 3.88 | Prevalence of cardiovascular autonomic neuropathy and gastroparesis symptoms among patients with type 2 diabetes who attend a primary health care center. ( AlHarbi, TJ; AlOlaiwi, LA; Tourkmani, AM, 2018) |
| " (MS) bark juice in diabetic gastroparesis and its effect on pharmacokinetic of metformin (MET)." | 3.83 | Influence of Musa sapientum L. on pharmacokinetic of metformin in diabetic gastroparesis. ( Darvhekar, V; Jyotishi, SG; Mazumder, PM; Shelke, PG; Tripathi, AS, 2016) |
| "Gastroparesis is a well-known consequence of long-standing diabetes that presents with gastric dysmotility in the absence of gastric outlet obstruction." | 1.91 | The role of mosapride and levosulpiride in gut function and glycemic control in diabetic rats. ( Akrab, SNA; Al Gawhary, NE; Morcos, GNB; Shafik, AN; Wissa, MY, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Akrab, SNA | 1 |
| Al Gawhary, NE | 1 |
| Shafik, AN | 1 |
| Morcos, GNB | 1 |
| Wissa, MY | 1 |
| AlOlaiwi, LA | 1 |
| AlHarbi, TJ | 1 |
| Tourkmani, AM | 1 |
| Darvhekar, V | 1 |
| Tripathi, AS | 1 |
| Jyotishi, SG | 1 |
| Mazumder, PM | 1 |
| Shelke, PG | 1 |
3 other studies available for metformin and Gastroparesis
| Article | Year |
|---|---|
The role of mosapride and levosulpiride in gut function and glycemic control in diabetic rats.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Gastroparesis; G | 2023 |
Prevalence of cardiovascular autonomic neuropathy and gastroparesis symptoms among patients with type 2 diabetes who attend a primary health care center.
Topics: Autonomic Nervous System; Blood Pressure; Cardiovascular System; Cross-Sectional Studies; Diabetes M | 2018 |
Influence of Musa sapientum L. on pharmacokinetic of metformin in diabetic gastroparesis.
Topics: Alloxan; Animals; Blood Glucose; Chromatography, High Pressure Liquid; Diabetes Mellitus, Experiment | 2016 |